News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Australia Biotech Hopeful Avexa Limited (AVX.AX) Debuts After Spinoff



10/19/2005 5:11:33 PM

Australian biotechnology company Avexa Ltd. (AVX.AU) debuted on the local stock exchange Thursday after Amrad Corp. (AML.AU) spun off its antiviral business into the new entity. Avexa, which is researching treatments for life-threatening illnesses such as HIV/AIDS and hepatitis B, opened at 28.5 cents, giving the company a market value of A$24.1 million.

Read at Dow Jones


comments powered by Disqus
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES